IndexIQ Advisors’s Natus Medical Inc NTUS Stock Holding History

IndexIQ Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$412K	Sell	15,683 -807	-5%	-$19.7K	0.01%	519
2021 Q4	$391K	Sell	16,490 -1,066	-6%	-$26.3K	0.01%	800
2021 Q3	$440K	Buy	17,556 +1,759	+11%	+$44.8K	0.01%	697
2021 Q2	$410K	Sell	15,797 -156	-1%	-$4.24K	0.01%	672
2021 Q1	$409K	Buy	15,953 +6,898	+76%	+$177K	0.01%	534
2020 Q4	$181K	Buy	9,055 +935	+12%	+$18.3K	0.01%	940
2020 Q3	$139K	Buy	8,120 +440	+6%	+$8.32K	0.01%	869
2020 Q2	$168K	Sell	7,680 -500	-6%	-$11.4K	0.01%	748
2020 Q1	$189K	Buy	+8,180	New	+$238K	0.01%	467

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IndexIQ Advisors's NTUS Position: Q1 2022 in Review

IndexIQ Advisors reduced its Natus Medical Inc (NTUS) stake by 4.9% in Q1 2022, selling an estimated $19.7K and leaving 15,683 shares worth $412K. The position accounts for 0.01% of the portfolio, ranked #519.

IndexIQ Advisors first reported a position in NTUS in Q1 2020 and has held it in 9 quarters since. The position peaked at $440K in Q3 2021. 172 funds tracked by Wall St. Rank hold NTUS as of Q1 2022.

IndexIQ Advisors held 15,683 shares of Natus Medical Inc worth $412K as of Q1 2022.
IndexIQ Advisors sold 807 Natus Medical Inc shares in Q1 2022, an estimated $19.7K.
Natus Medical Inc made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #519 holding.
IndexIQ Advisors first reported a position in Natus Medical Inc in Q1 2020 and has held it in 9 quarters since.
IndexIQ Advisors's Natus Medical Inc position peaked at $440K in Q3 2021.
172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.